Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
Circulation|December 19, 2001
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)A M Wallace, A D McMahon, C J Packard, et al.
International Journal of Obesity (2005)|February 14, 2015
Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60-64 years: evidence from the 1946 birth cohortE T Murray, R Hardy, A Hughes, et al.
Clinical Science (London, England : 1979)|April 27, 2000
Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular diseaseS J Cleland, N Sattar, J R Petrie, et al.
BJU International|March 2, 2002
The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancerZ Latif, D C McMillan, A M Wallace, et al.
Human Reproduction (Oxford, England)|June 22, 1999
Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory processA J Thomson, J F Telfer, A Young, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|June 11, 1998
Associations of indices of adiposity with atherogenic lipoprotein subfractionsN Sattar, C E Tan, T S Han, et al.
European Journal of Clinical Nutrition|January 28, 2005
Effect of CLA supplementation on immune function in young healthy volunteersH-J Song, I Grant, D Rotondo, et al.
Pediatric Obesity|July 30, 2013
Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohortL Graves, S P Garnett, C T Cowell, et al.
Diabetologia|August 24, 2011
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health StudyS G Wannamethee, O Papacosta, D A Lawlor, et al.
Health Technology Assessment (Winchester, England)|November 9, 2011
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic reviewD Shyangdan, C Clar, N Ghouri, et al.
Pageof 26